Viewing data from:

TIAGABINE HYDROCHLORIDE

ANDA

TIAGABINE HYDROCHLORIDE | A214816 | MSN LABORATORIES PRIVATE LTD

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: GABITRIL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$6.02

per ea

Lowest NADAC/Unit

$2.06

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
72205008630TIAGABINE HCL 12 MG TABLET	$6.02	EA	Generic	—	2026-05-20
72205008430TIAGABINE HCL 2 MG TABLET	$2.21	EA	Generic	—	2026-06-17
72205008530TIAGABINE HCL 4 MG TABLET	$2.06	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs3 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SUN PHARMACEUTICAL INDUSTRIES LTDTIAGABINE HYDROCHLORIDE USP

DMF 179782005

CHEMWERTH INCTIAGABINE HYDROCHLORIDE

DMF 220332008

MSN LIFE SCIENCES PRIVATE LTDTIAGABINE HYDROCHLORIDE USP

DMF 334942018

RANBAXY LABORATORIES LTDInactiveTIAGABINE HYDROCHLORIDE USP

DMF 189342005

UNICHEM LABORATORIES LTDInactiveTIAGABINE HYDROCHLORIDE USP

DMF 272862013

SIGNA SA DE CVInactiveTIAGABINE HYDROCHLORIDE MONOHYDRATE USP

DMF 273802013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — 2MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Nov 16, 2021

No patent or exclusivity listings for this strength.

#002 — 4MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 16, 2021

#003 — 12MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 16, 2021

#004 — 16MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 16, 2021